USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
26 Mar 2021 | North America | Customer Research
Global Laboratory Product Purchasing Trends, 2020–2021
An End-user Perspective on Laboratory Spending Reveals Modest 2021 Budget Increases Following Healthier 2020 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents yea...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Jan 2021 | North America | Tracker
Artificial Intelligence Powering the Global Medical Imaging Market
Efficiency Tools and Workflow Optimization to Drive Future Growth Potential
The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing chan...
$7,500.00
Special Price $5,625.00 save 25 %
-
09 Oct 2019 | North America | Frost Radar
Frost Radar in the US Healthcare Data Analytics Market
A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines
US-based providers lose an estimated $260 billion to $270 billion annually due to poor financial risk management and lack of infrastructure to support data-driven business decisions. For every dollar claimed, private and public payers on average offer a reimbursement of 86 cents to providers, resulting in a negative margin of 14% per dollar per pat...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Sep 2019 | North America | Frost Radar
Frost Radar in the Immunoassay and Clinical Chemistry Market
A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines
The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Apr 2019 | Latin America | Customer Research
Provider CIO and IT Executive Views on the Healthcare Information Technology Market in Brazil
Leading Growth Opportunities Include Enterprise Content Management, Clinical Decision Support Systems, and Telehealth
Adoption of healthcare information technology (IT) in Brazil has been increasing at a moderate pace, with good possibilities ahead as the country moves to more solid economic ground. Brazil presents great opportunities for growth in the near future, based on four major pillars: • Huge healthcare infrastructure • Potential gross domestic produ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Dec 2014 | North America | Customer Research
2015 Global Laboratory Products Purchasing Trends
End-user Perspective
Readers of the Lab Manager Magazine were invited to participate in an online survey in September 2014. To qualify for survey participation, readers were required to play a role in their laboratory’s purchasing process, be familiar with their laboratories’ product budgets, and represent a laboratory that either uses or plans to use products in o...
$6,950.00
Special Price $5,212.50 save 25 %
-
22 Sep 2014 | North America | Customer Research
Global Next-generation Sequencing Trends
An End-user Perspective
The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house NGS technology use is expected to increase within the next 12 months. Data accuracy and operating costs are the top criteria for purchasing sequencing instruments. Disease-r...
$3,950.00
Special Price $2,962.50 save 25 %
-
24 Jan 2014 | Global | Tracker
2014 Projected Global Laboratory Products Budgets
Brands Evaluated, Purchasing Trends Identified
The primary aim of this study is to establish the size of laboratory budgets for the purchasing of products in 7 categories and the baselines for developing trends (2013 to 2014). Additionally, this research investigates the factors that drive selection of laboratory products and how these products are associated with factors driving selection. Ove...
$10,000.00
Special Price $7,500.00 save 25 %
